The company is building the clinical intelligence and intervention layer to deliver whole-person cancer care at scale.
U.S. procurement rules will prohibit Chinese origin rare earth materials in defense applications from January 2027. China ...
It’s revenue from operations rose 26 percent to Rs 458.25 crore in the reported quarter over Rs 363.66 crore in the year-ago ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results